京新药业:公司的降脂新药PL(a)JX2201的临床I期接近尾声

中金财经
Feb 08

  证券之星消息,京新药业(002020)02月08日在投资者关系平台上答复投资者关心的问题。投资者提问:问吕董,公司降脂新药PL(a)JX2201一期临床效果达到预期效果了吗?优与同期其它同类药品吗?京新药业回复:您好!公司的降脂新药PL(a)JX2201的临床I期接近尾声。谢谢!为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10